Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

Rose AH!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
carlson Member Profile
 
Followed By 115
Posts 16,349
Boards Moderated 1
Alias Born 06/10/12
160x600 placeholder
Notice of Exempt Solicitation. Definitive Material. (px14a6g) Edgar (US Regulatory) - 3/26/2020 6:04:46 AM
Gilead Withdraws Application for Orphan-Drug Status Dow Jones News - 3/25/2020 5:41:00 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/24/2020 4:07:12 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/24/2020 4:07:01 PM
FDA Approves Supplemental New Drug Application for Gilead Sciences Treatment Dow Jones News - 3/19/2020 3:48:00 PM
U.S. Food And Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir) for Children Ages 6 & Older or Weighing at Leas... Business Wire - 3/19/2020 2:40:00 PM
Trump Says U.S. Will Cut Red Tape to Advance Virus Therapies -- Update Dow Jones News - 3/19/2020 1:03:00 PM
Trump Directs FDA to Eliminate Red Tape to Fight Virus Dow Jones News - 3/19/2020 12:39:00 PM
New Clinical Study Data for Gilead’s Investigational HIV-1 Capsid Inhibitor GS-6207 Presented at CROI 2020 Business Wire - 3/11/2020 3:09:00 PM
Gilead Unveils Results From HIV Phase 1b Trial Dow Jones News - 3/10/2020 3:37:00 PM
Treatment With Gilead’s Vesatolimod Is Evaluated for Safety & Virologic & Immunologic Response Versus Placebo in Phase 1B H... Business Wire - 3/10/2020 2:33:00 PM
Gilead Presents 96-week DISCOVER Trial Data Demonstrating Favorable Renal & Bone Safety Profile of Descovy® for HIV PrEP in ... Business Wire - 3/10/2020 11:32:00 AM
New Data on Gilead’s Biktarvy® Presented at CROI 2020, Including Data in Black Americans and Older Adults Business Wire - 3/9/2020 2:53:00 PM
New Leadership for Gilead Sciences Canada, Inc. - Melissa Koomey Appointed Vice President and General Manager PR Newswire (Canada) - 3/5/2020 9:00:00 AM
Nouvelle direction pour Gilead Sciences Canada, Inc. - Melissa Koomey est nommée vice-présidente et directrice générale PR Newswire (Canada) - 3/5/2020 9:00:00 AM
WeissLaw LLP Investigates Forty Seven, Inc. PR Newswire (US) - 3/3/2020 5:36:00 PM
Gilead Bulks Up Oncology Pipeline -- WSJ Dow Jones News - 3/3/2020 3:02:00 AM
Forty Seven Shares Surge 60% on Takeover by Gilead Dow Jones News - 3/2/2020 10:52:00 AM
(FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal? PR Newswire (US) - 3/2/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2020 7:45:18 AM
Gilead Science to Buy Forty Seven Inc. for $4.9 Billion Dow Jones News - 3/2/2020 7:44:00 AM
Gilead to Acquire Forty Seven for $4.9 Billion Business Wire - 3/2/2020 6:55:00 AM
Microsoft, Walt Disney, Gilead Sciences: Stocks That Defined the Week -- WSJ Dow Jones News - 2/29/2020 3:02:00 AM
Microsoft, Walt Disney, Gilead Sciences: Stocks That Defined the Week Dow Jones News - 2/28/2020 7:05:00 PM
Gilead to Kick Off Its Own Studies of Potential Coronavirus Drug--Update Dow Jones News - 2/26/2020 6:22:00 PM
carlson   Wednesday, 02/05/20 10:41:41 PM
Re: mick post# 2888
Post # of 3077 
Rose AH!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist